Cerebrospinal fluid CXCL13 identifies a subgroup of people living with HIV with prominent intrathecal synthesis, immune activation, and neurocognitive impairment regardless of effective antiretroviral therapy

Mattia Trunfio, Lorenzo Mighetto, Laura Napoli, Cristiana Atzori, Marco Nigra, Giulia Guastamacchia, Stefano Bonora, Giovanni Di Perri, Andrea Calcagno
doi: https://doi.org/10.1101/2022.12.13.22283427

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Back to top
Posted December 14, 2022.
Download PDF

Supplementary Material

Data/Code
Email
Cerebrospinal fluid CXCL13 identifies a subgroup of people living with HIV with prominent intrathecal synthesis, immune activation, and neurocognitive impairment regardless of effective antiretroviral therapy
Mattia Trunfio, Lorenzo Mighetto, Laura Napoli, Cristiana Atzori, Marco Nigra, Giulia Guastamacchia, Stefano Bonora, Giovanni Di Perri, Andrea Calcagno
medRxiv 2022.12.13.22283427; doi: https://doi.org/10.1101/2022.12.13.22283427
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area